![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
News
UNICEF to lead procurement and supply of COVID-19 vaccines in world’s largest and fastest ever operation of its kind
UNICEF is leading efforts to procure and supply COVID-19 vaccines in what could possibly be the world’s largest and fastest ever procurement and supply...
News
Mesoblast Limited receives ethics approval to treat COVID-19 patients in Australia
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in thePhase...
News
Delivery of COVID-19 vaccine: DHL study shows how public and private sector can partner for success
With first emergency use authorizations for COVID-19 vaccines expected to be effective in the last quarter of 2020, logistics providers are challenged to rapidly...
Clinical Trials
Bharat Biotech gets approval to conduct phase 2 trials of COVID-19 vaccine Covaxin
Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine Covaxin from September 7.
The Directorate General of Health Service...
Clinical Trials
Early trials find Russia’s Sputnik V safe, volunteers develop coronavirus antibodies within 3 weeks
Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts...
News
CureVac to Receive 252million Euros to Support COVID-19 Vax Development
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) in clinical trials, has received notification...
Drug Research
Enesi Pharma partners with Adelaide University for Zika vaccine
Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read